Direkt zum Inhalt
Merck
Alle Fotos(2)

Wichtige Dokumente

Gesamtdokumentation anzeigen

D1068

Sigma-Aldrich

DCB

≥98% (HPLC), solid

Synonym(e):

3,3′-Dichlorobenzaldazine, NSC 67224

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise

Größe auswählen

10 MG
€ 107,00
50 MG
€ 300,00

€ 107,00

Check Cart for Availability
Bulk-Bestellung anfordern
Alle Fotos(2)

Größe auswählen

Ansicht ändern
10 MG
€ 107,00
50 MG
€ 300,00

About This Item

Empirische Formel (Hill-System):
C14H10Cl2N2
CAS-Nummer:
6971-97-7
Molekulargewicht:
277.15
MDL-Nummer:
MFCD00556081
UNSPSC-Code:
12352200
PubChem Substanz-ID:
24724458
NACRES:
NA.77

€ 107,00

Check Cart for Availability
Bulk-Bestellung anfordern

Assay

≥98% (HPLC)

Form

solid

Lagerbedingungen

desiccated
under inert gas

Farbe

yellow

Löslichkeit

DMSO: ~6.8 mg/mL
H2O: insoluble

Lagertemp.

2-8°C

SMILES String

Clc1cccc(\C=N\N=C\c2cccc(Cl)c2)c1

InChI

1S/C14H10Cl2N2/c15-13-5-1-3-11(7-13)9-17-18-10-12-4-2-6-14(16)8-12/h1-10H/b17-9+,18-10+

InChIKey

XMOVWXSCYLINBJ-BEQMOXJMSA-N

Biochem./physiol. Wirkung

3,3′-dichlorobenzaldazine (DCB) serves as an allosteric ligand with neutral cooperativity. It helps to block the positive allosteric regulation of mGluRs (metabotropic glutamate receptor subtype 5 (mGluR5) with the help of 3,3′-difluorobenzaldazine (DFB) and the negative modulatory effect of 3,3′-dimethoxybenzaldazine (DMeOB).[1]
Neutral allosteric modulator of the metabotropic glutamate receptor mGluR5.

Leistungsmerkmale und Vorteile

This compound is featured on the Glutamate Receptors (G Protein Family) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

Signalwort

Danger

Gefahreneinstufungen

Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Eye Dam. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3

Zielorgane

Respiratory system

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Persönliche Schutzausrüstung

dust mask type N95 (US), Eyeshields, Faceshields, Gloves

Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number
045K4622

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Suche nach COA

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Pierre Josse et al.
Molecules (Basel, Switzerland), 23(4) (2018-04-21)
The synthesis and preliminary evaluation as donor material for organic photovoltaics of the poly(diketopyrrolopyrrole-spirobifluorene) (PDPPSBF) is reported herein. Prepared via homogeneous and heterogeneous direct (hetero)arylation polymerization (DHAP), through the use of different catalytic systems, conjugated polymers with comparable molecular weights
Dieuwertje Van der Does et al.
PLoS genetics, 13(6), e1006832-e1006832 (2017-06-13)
Plants actively perceive and respond to perturbations in their cell walls which arise during growth, biotic and abiotic stresses. However, few components involved in plant cell wall integrity sensing have been described to date. Using a reverse-genetic approach, we identified
Angelo Silverio et al.
JACC. Cardiovascular interventions, 13(7), 793-804 (2020-02-18)
The aim of this study was to investigate the outcomes of patients with de novo lesions in small coronary vessels undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCBs) or newer-generation drug-eluting stents (n-DES). Notwithstanding the available evidence from a
Yvonne Bausback et al.
Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 24(4), 459-467 (2017-06-01)
To evaluate the performance of the Ranger paclitaxel-coated balloon vs uncoated balloon angioplasty for femoropopliteal lesions. Between January 2014 and October 2015, the prospective, randomized RANGER SFA study ( ClinicalTrials.gov identifier NCT02013193) enrolled 105 patients with symptomatic lower limb ischemia
Thomas Zeller et al.
JACC. Cardiovascular interventions, 13(4), 431-443 (2020-02-23)
The goal of this study was to evaluate the 5-year follow-up data of the IN.PACT DEEP (Randomized IN.PACT Amphirion Drug-Coated Balloon [DCB] vs. Standard Percutaneous Transluminal Angioplasty [PTA] for the Treatment of Below-the-Knee Critical Limb Ischemia [CLI]) trial. Initial studies
Alle zugehörigen Dokumente anzeigen

Questions

Reviews

No rating value

Active Filters

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.